封面
市場調查報告書
商品編碼
1098682

人乳寡糖市場規模/份額/前景/機會(2022-2030):按用途/地區

Human Milk Oligosaccharides Market, By Application, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

提高對母乳低聚醣對健康益處的認識有望推動母乳低聚醣市場的增長。預計增加人乳低聚醣在食品補充劑和功能性食品和飲料中的使用也將推動市場增長。另一方面,母乳喂養意識的提高和高生產成本預計將抑制市場增長。

本報告調查了全球母乳低聚醣市場,定義和概述了市場,分析了對市場增長、法律和監管環境、市場規模變化和預測以及各個類別和地區的各種影響因素。/主要國家細分、競爭環境、主要公司概況等匯總。

目錄

第 1 章調查目標/先決條件

第二章市場概述

第三章市場動態/監管/趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/批准
  • PEST 分析
  • 波特分析
  • 併購場景

第 4 章全球母乳低聚醣市場:COVID-19 的影響

  • COVID-19:流行病學
  • 供給側/需求側分析
  • 經濟影響

第 5 章全球母乳低聚醣市場:按用途

  • 嬰幼兒奶粉
  • 膳食補充劑
  • 功能性食品和飲料

第 6 章全球母乳低聚醣市場:按地區劃分

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
  • 其他領域

第8章競爭態勢

  • ZuChem Inc.
  • Merck & Co. Inc.
  • Hansen Holding AS
  • Royal FrieslandCampina NV
  • BASF
  • IFF
  • Gnubiotics
  • Inbiose NV
  • Carbosynth Holdings Limited
  • Royal DSM N.V
  • 分析師見解

第9章 章節

簡介目錄
Product Code: CMI5064

A major role in the infant's development is played by human milk oligosaccharides, which are structurally complex glycans found in breast milk. Human milk oligosaccharides (HMOs) are known to promote the growth of beneficial gut bacteria, stimulate the immune system, and aid brain development.

Market Dynamics:

Growing awareness regarding health benefits of human milk oligosaccharides is expected to drive market growth. Additionally, increasing use of HMOs in food supplements and functional food & beverage products is again projected to foster market growth. In May 2021, NewAge, Inc., announced the launch of Nutrifii Kids™ Chewable Multivitamin, a daily supplement for support of the healthy development and immune systems of children and adolescents.

On the other hand, growing awareness regarding breastfeeding and high cost of production is expected to restrict the growth of human milk oligosaccharides market.

Key features of the study:

  • This report provides in-depth analysis of the global human milk oligosaccharides market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global human milk oligosaccharides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include ZuChem Inc., Merck & Co. Inc., Chr. Hansen Holding AS (Jennewein Biotechnologie GmbH), Royal FrieslandCampina NV, BASF, IFF (DuPont Nutrition & Health), Gnubiotics, Inbiose NV, Carbosynth Holdings Limited, and Royal DSM N.V
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global human milk oligosaccharides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human milk oligosaccharides market

Detailed Segmentation:

  • Global Human Milk Oligosaccharides Market, By Application:
  • Infant Formula
  • Dietary Supplements
  • Functional Food and Beverage
  • Global Human Milk Oligosaccharides Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market HUMAN MILK OLIGOSACCHARIDES, By APPLICATION
    • Market HUMAN MILK OLIGOSACCHARIDES, By REGION
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing awareness regarding health benefits of HMO
    • High production cost
    • Integration of HMO in supplements and functional food
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Human Milk Oligosaccharides Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Human Milk Oligosaccharides Market, By Application, 2022-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Infant Formula
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Functional Food and Beverage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Human Milk Oligosaccharides Market, By Region, 2022-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2017-2028
    • Country Trends

7.

  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

8. Competitive Landscape

  • ZuChem Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hansen Holding AS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Royal FrieslandCampina NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IFF
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Gnubiotics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Inbiose NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Carbosynth Holdings Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Royal DSM N.V
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us